NFE2L2 and retinal ischemia: Nrf2-activating drugs, such as triterpenoids, inhibitors of the Keap1-Nrf2 protein-protein or monomethyl fumarate reduced oxidative stress and RGC death during retinal ischemia [314,334,335].